Zhiyuan Hu Selected Research

Alzheimer Disease (Alzheimer's Disease)

4/2024	Biomimetic Nanovesicles as a Dual Gene Delivery System for the Synergistic Gene Therapy of Alzheimer's Disease.
10/2023	A Reactive Oxygen Species-Responsive Targeted Nanoscavenger to Promote Mitophagy for the Treatment of Alzheimer's Disease.
1/2022	Corrigendum: Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer's Disease in Blood.
1/2021	Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer's Disease in Blood.
2/2020	Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease by the Plasma and Serum Amyloid-beta 42 Assay through Highly Sensitive Peptoid Nanosheet Sensor.
8/2017	Antibody-Mimetic Peptoid Nanosheet for Label-Free Serum-Based Diagnosis of Alzheimer's Disease.
1/2017	Antiamyloidogenic Activity of Aβ42-Binding Peptoid in Modulating Amyloid Oligomerization.
1/2015	Label-free detection of Alzheimer's disease through the ADP3 peptoid recognizing the serum amyloid-beta42 peptide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhiyuan Hu Research Topics

Disease

78	Neoplasms (Cancer) 02/2024 - 08/2004
28	Breast Neoplasms (Breast Cancer) 01/2024 - 08/2004
12	Circulating Neoplastic Cells 07/2023 - 04/2013
8	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 01/2015
5	Lung Neoplasms (Lung Cancer) 01/2020 - 03/2009
4	Pathologic Complete Response 09/2023 - 03/2009
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 10/2015
4	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2009
3	Glioma (Gliomas) 06/2023 - 01/2022
3	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 04/2007
2	Body Weight (Weight, Body) 06/2023 - 04/2004
2	Triple Negative Breast Neoplasms 01/2022 - 12/2019
2	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 03/2009
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2021
2	Liver Neoplasms (Liver Cancer) 01/2020 - 12/2008
2	Colonic Neoplasms (Colon Cancer) 01/2020 - 04/2007
2	Hypertension (High Blood Pressure) 01/2019 - 01/2018
2	Disease Progression 01/2019 - 01/2014
2	Carcinogenesis 01/2018 - 01/2017
2	Weight Loss (Weight Reduction) 09/2007 - 04/2004
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2023
1	Multiple Myeloma 12/2023
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 08/2023
1	Bites and Stings (Sting) 01/2022
1	Carcinoma (Carcinomatosis) 01/2021

Drug/Important Bio-Agent (IBA)

30	Peptides (Polypeptides)IBA 12/2023 - 04/2007
18	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2009
13	Proteins (Proteins, Gene)FDA Link 01/2024 - 08/2004
12	Estrogen ReceptorsIBA 01/2024 - 08/2004
12	Phenobarbital (Luminal)FDA Link 09/2023 - 08/2004
8	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2018
7	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 06/2008
7	Liposomes (Liposome)IBA 01/2020 - 04/2016
6	PeptoidsIBA 01/2022 - 01/2015
5	Messenger RNA (mRNA)IBA 01/2024 - 04/2004
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2019
5	AntibodiesIBA 01/2022 - 08/2004
5	human ERBB2 proteinIBA 01/2022 - 04/2016
4	Immune Checkpoint InhibitorsIBA 07/2023 - 01/2018
4	Trastuzumab (Herceptin)FDA Link 10/2020 - 01/2017
4	Albumin-Bound Paclitaxel FDA Link 12/2019 - 01/2015
3	EnzymesIBA 01/2023 - 04/2007
3	Monoclonal AntibodiesIBA 12/2021 - 01/2018
3	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2018
3	LigandsIBA 01/2019 - 05/2007
3	DNA (Deoxyribonucleic Acid)IBA 11/2018 - 01/2007
3	Nucleic AcidsIBA 01/2018 - 01/2012
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 04/2006
3	Peptide LibraryIBA 01/2016 - 04/2007
2	Amyloid (Amyloid Fibrils)IBA 04/2024 - 01/2017
2	apatinibIBA 02/2024 - 01/2019
2	Tamoxifen FDA LinkGeneric 01/2024 - 04/2006
2	ElementsIBA 12/2023 - 01/2019
2	Coloring Agents (Dyes)IBA 12/2023 - 05/2018
2	taxaneIBA 09/2023 - 03/2009
2	P-2 (P 2)IBA 09/2023 - 03/2009
2	AnthracyclinesIBA 09/2023 - 03/2009
2	Sincalide FDA Link 06/2023 - 11/2022
2	Therapeutic UsesIBA 01/2023 - 01/2016
2	Small Cytoplasmic RNAIBA 10/2022 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2018
2	Epithelial Cell Adhesion MoleculeIBA 01/2020 - 12/2015
2	plastinIBA 12/2019 - 01/2019
2	MicellesIBA 01/2019 - 06/2008
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019 - 01/2018
2	ImmunosorbentsIBA 08/2018 - 04/2007
2	AmberIBA 01/2018 - 03/2016
2	Hormones (Hormone)IBA 01/2018 - 04/2006
2	Keratins (Keratin)IBA 01/2018 - 08/2004
2	AlbuminsIBA 01/2017 - 10/2015
2	Blood Proteins (Serum Proteins)IBA 01/2014 - 12/2008
2	Fatty Acid Synthases (Fatty Acid Synthase)IBA 09/2007 - 04/2004
1	toripalimabIBA 02/2024
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 12/2023
1	Molecular Probes (Molecular Probe)IBA 12/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2023
1	OxidesIBA 08/2023
1	Dipeptidyl-Peptidase IV InhibitorsIBA 06/2023
1	Temozolomide (Temodar)FDA LinkGeneric 06/2023
1	Blood Glucose (Blood Sugar)IBA 06/2023
1	Sitagliptin Phosphate (Januvia)FDA Link 06/2023
1	Glucosamine 6-Phosphate N-Acetyltransferase (Glucosamine-Phosphate N-Acetyltransferase)IBA 01/2023
1	HexosaminesIBA 01/2023
1	MethyltransferasesIBA 11/2022
1	N-methyladenosineIBA 11/2022
1	7-hydroxycoumarin-3-acetic acid N-hydroxysuccinimidyl esterIBA 10/2022
1	NanocapsulesIBA 01/2022
1	Circular RNAIBA 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	InterferonsIBA 01/2022
1	ProdrugsIBA 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	B7-H1 AntigenIBA 12/2021

Therapy/Procedure

38	Therapeutics 02/2024 - 04/2007
7	Immunotherapy 09/2023 - 01/2021
4	Drug Therapy (Chemotherapy) 09/2023 - 03/2009
4	Precision Medicine 01/2019 - 01/2019
3	Neoadjuvant Therapy 01/2022 - 11/2018
1	Segmental Mastectomy (Lumpectomy) 01/2022